Evidencias y Ensayos clínicos

• L.OVE Covid-19 evidence

• Living Evidence on COVID-19

• Covid-End McMaster University

• Diana Salud. Divulgación de Iniciativas para Analizar la Adecuación en Salud

• Evidencias COVID-19 Cochrane

• Revisiones Cochrane Covid19

• Covid Reviews de Cochrane

• Registro de estudios covid-19 Cochrane

• Coronavirus (covid-19) - recursos y noticias de Cochrane

• COVID-19 Evidence Synthesis Resources

https://evidencesynthesisireland.ie/covid-19-evidence-synthesis-resources/

• PREEVID. Banco de preguntas sobre COVID-19

https://www.murciasalud.es/preevid.php?op=banco&tema=761&idsec=453

• COVID-19: living map of the evidence

http://eppi.ioe.ac.uk/COVID19_MAP/covid_map_v3.html

• Living mapping and living systematic review of Covid-19 studies

https://covid-nma.com/

• Health Technology Assessments

• Bibliografía Ensayos (actualizado a 23 abril - 3 referencias)

1. Keshtkar-Jahromi M, Bavari S. A Call for Randomized Controlled Trials to Test the Efficacy of Chloroquine and Hydroxychloroquine as Therapeutics against Novel Coronavirus Disease (COVID-19). The American Journal of Tropical Medicine and Hygiene [Internet]. 3 de abril de 2020 [citado 23 de abril de 2020]; Disponible en: http://www.ajtmh.org/content/journals/10.4269/ajtmh.20-0230

2. Gautret P, Lagier J-C, Parola P, Hoang VT, Meddeb L, Mailhe M, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. International Journal of Antimicrobial Agents. marzo de 2020;105949.

3. Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Research. junio de 2020;178:104787.